NORWALK, CT – Mederi Therapeutics Inc. today announced two milestones in the worldwide growth of Stretta Therapy for GERD, which include the completion of the 18,000th Stretta procedure and new regulatory approvals in OUS markets of Mexico, India, South Africa, Australia, Argentina and South Korea.
CHARLTON, MA – MTD Micro Molding (www.mtdmicromolding.com), a long-time leader in micro-injection molding, has promoted Operations Manager Gary Hulecki to Executive Vice President.
Gary’s dedication and focus on building a team that supports MTD’s culture to “Be the First” and to “Be the Best” has enabled MTD to grow steadily. Gary’s new role will expand his responsibilities to include Sales, Marketing, Process Engineering, Office Management and Quality.
“I look forward to working with Gary as MTD continues to expand and promote capabilities that enable our customers to create challenging medical devices that improve the quality of life”, said Dennis Tully, President at MTD.
BOSTON, MA – Halloran Consulting Group, the life science management consulting firm, expands its robust range of clinical finance capabilities with the addition of the industry’s leading financial forecasting tool.
FRANKLIN, MA – Tegra Medical, a premium quality contract manufacturer for the medical device industry, is pleased to announce that Craig Campbell has joined the company as Chief Financial Officer. Craig will be responsible for all finance, accounting and IT functions and will report to J. Mark King, the Company’s President and Chief Executive Officer.
IVYLAND, PA – Vistek Medical, a leading contract manufacturer of medical implants and components focused on the Orthopedic, Spinal, Trauma, and Extremity markets has reached a manufacturing milestone of two million medical components.
“This landmark reflects the dedication of our employees and commitment to delivering precision machined medical components to our customers on time,” stated John Ducaji, director of sales and business development.
BOSTON–Halloran Consulting Group, Inc. (Halloran) today announced its collaboration with Veeva Systems (Veeva), providing a combination of technology and services to enable rapid access to Vault eTMF and ongoing Trial Master File (TMF) maintenance.
NORWALK, Conn. — A newly published, pathologist-blinded study in a porcine model, examines the histopathology changes after non-ablative radiofrequency (NARF) to smooth muscle as delivered by Stretta therapy for GERD and Secca therapy for fecal incontinence. Radiofrequency therapy is commonly thought of in terms of ablation, where tissue destruction occurs.